Hidetoshi Akita
Overview
Explore the profile of Hidetoshi Akita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
114
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimizu N, Moritoki Y, Katsumi N, Yanase T, Sugino T, Kanemoto K, et al.
Case Rep Urol
. 2022 Sep;
2022:6082700.
PMID: 36157380
Plasmacytoid urothelial carcinoma (PUC) of the bladder is a rare variant of invasive urothelial carcinoma (UC) with aggressive behavior. Despite its prognosis being poorer than that of conventional UC, a...
2.
Noda Y, Naiki T, Sugiyama Y, Nagai T, Naiki-Ito A, Kawai T, et al.
Oncology
. 2022 Jun;
100(8):429-438.
PMID: 35760062
Introduction: This study had two objectives: (i) to evaluate oncological outcomes in a long-term follow-up of patients with bladder cancer after reduced-port laparoscopic radical cystectomy (RP-LRC) and (ii) to assess...
3.
Yanase T, Moritoki Y, Kondo H, Ueyama D, Akita H, Yasui T
Urol Case Rep
. 2020 Dec;
34:101508.
PMID: 33318935
Ipilimumab plus nivolumab (Ipi/Nivo) has revolutionized advanced renal cell carcinoma (RCC) treatment. However, it encompassed fatal immune-related adverse events (irAEs). Myocarditis with concomitant myasthenia gravis (MG) has a mortality rate...
4.
Nagai T, Okamura T, Katayama K, Chaya R, Tanaka Y, Kobayashi D, et al.
IJU Case Rep
. 2020 Aug;
1(1):22-24.
PMID: 32743358
Introduction: Creation of an ileal conduit is associated with complications. A few cases have been reported on tumor development in an ileal conduit; diffuse large B-cell lymphoma originating from an...
5.
Chaya R, Okamura T, Yanase T, Nagai T, Moritoki Y, Kobayashi D, et al.
J Rural Med
. 2020 Feb;
15(1):25-28.
PMID: 32015778
Cabazitaxel (CBZ) is used worldwide for castration-resistant prostate cancer after docetaxel treatment. In July 2014 the drug was approved in Japan with the same induction dose used for Caucasian patients....
6.
Oyama H, Nagai T, Okamura T, Yanase T, Chaya R, Moritoki Y, et al.
J Rural Med
. 2019 Dec;
14(2):241-244.
PMID: 31788150
A 76-year-old Japanese man visited a nearby medical clinic complaining of abdominal distention. He had undergone extraperitoneal laparoscopic prostatectomy at our institution 5 months before the onset of abdominal distention....
7.
Nagai T, Naiki T, Iida K, Nozaki S, Etani T, Sugiyama Y, et al.
Asian Pac J Cancer Prev
. 2019 Oct;
20(10):2995-3000.
PMID: 31653146
Background: Patients with metastatic urothelial carcinoma (mUC) have an uncertain prognosis. The aim of the current study was to evaluate the prognostic potential of a skeletal muscle mass reduction index...
8.
Nagai T, Okamura T, Taki Y, Tanaka Y, Kobayashi D, Kobayashi T, et al.
Int Cancer Conf J
. 2019 Jun;
6(4):171-174.
PMID: 31149496
A 45-year-old Japanese man, who was undergoing HIV infection treatment, was aware that he had gross hematuria, and he was diagnosed as having a ureteral tumor by radiographic examination. Therefore,...
9.
Nagai T, Okamura T, Tanaka Y, Moritoki Y, Kobayashi D, Kobayashi T, et al.
Asian Pac J Cancer Prev
. 2019 May;
20(5):1389-1392.
PMID: 31127897
Objective: Bacillus Calmette-Guèrin (BCG) intravesical therapy is currently established using a low dose because
of the high incidence of side-effects. Moreover, shortening the dwell time of BCG is conducted in...
10.
Nagai T, Okamura T, Yanase T, Chaya R, Moritoki Y, Kobayashi D, et al.
Asian Pac J Cancer Prev
. 2019 Apr;
20(4):1271-1273.
PMID: 31030505
Objective: UroVysion (Abbott Molecular, Inc., Illinois, USA) is based on multicolor fluorescence in situ hybridization
(FISH). It has been used successfully in the USA following its Food and Drug Administration...